RT Journal
A1 Qureshi ZP, Sartor O, Xirasagar S, Liu Y, Bennett CL
T1 PHarmaceutical fraud and abuse in the united states, 1996-2010
JF Archives of Internal Medicine
JO Archives of Internal Medicine
YR 2011
FD September 12
VO 171
IS 16
SP 1503
OP 1506
DO 10.1001/archinternmed.2011.397
UL http://dx.doi.org/10.1001/archinternmed.2011.397
AB 
Prescription drug spending totaled $234 billion in 2008 (up from $40 billion in 1990) and accounted for 10% of health care expenditures.1 Pharmaceutical fraud may be an important component of health care costs. Between 1996 and 2005, $3.6 billion was recovered for 13 pharmaceutical fraud cases initiated by “whistle blowers” (termed qui tam relators). These recoveries, despite accounting for 3% of the number of federal fraud cases involving health care, accounted for 40% of federal fraud financial recoveries involving qui tam relators.2 We report on pharmaceutical fraud investigations completed between 1996 and 2010 regardless of qui tam relator involvement status.